ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,953.45
0.38%
US Tech 100
20,863.60
0.56%
Dow Jones
42,789.62
-0.12%
Brent Oil
72.19
-0.72%
Bitcoin
93,376.66
-1.82%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Biogen Inc (1BIIB) Quote

Biogen Inc

Biogen Inc (1BIIB)

BIT
141.55
0.00
(0.00%)
Closed December 23 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
141.55
Bid
142.00
Ask
142.75
Volume
0.00
0.00 Day's Range 0.00
141.45 52 Week Range 244.60
Market Cap
20.627B
Previous Close
141.55
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
41
Shares Outstanding
145,719,340
Dividend Yield
-
PE Ratio
18.56
Earnings Per Share (EPS)
7.97
Revenue
9.84B
Net Profit
1.16B

About Biogen Inc

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.biogen.com
Headquarters
Wilmington, Delaware, USA
Founded
-
Biogen Inc is listed in the Biological Pds,ex Diagnstics sector of the Italian Stock Exchange with ticker 1BIIB. The last closing price for Biogen was 141.55 €. Over the last year, Biogen shares have traded in a share price range of 141.45 € to 244.60 €.

Biogen currently has 145,719,340 shares outstanding. The market capitalization of Biogen is 20.63 € billion. Biogen has a price to earnings ratio (PE ratio) of 18.56.

Ask ADVFN Intelligence (AI)

1BIIB Latest News

More News

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity Dapirolizumab pegol (DZP) met its...

November 19 2024
UK Regulatory

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease TOKYO and CAMBRIDGE, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Eisai Co., Ltd...

November 14 2024
UK Regulatory

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference

Eisai Presents Data on Benefits of Long-Term Administration of Dual-Acting Lecanemab at the 17th Clinical Trials for Alzheimer’s Disease (CTAD) Conference -New testing method highlights link...

October 30 2024
UK Regulatory

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases

Biogen and Neomorph Announce Multi-Target Research Collaboration to Discover and Develop Molecular Glue Degraders for Alzheimer’s, Rare, and Immunological Diseases The collaboration aims to...

October 29 2024
UK Regulatory

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer

Biogen Appoints Daniel Quirk, MD, as Chief Medical Officer CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) has appointed Daniel Quirk, M.D., M.P.H., M.B.A. as...

October 29 2024
UK Regulatory

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025

Michael McDonnell, Executive Vice President and Chief Financial Officer to Retire in February 2025 Robin Kramer, Chief Accounting Officer, to Succeed HimCAMBRIDGE, Mass., Oct. 28, 2024 (GLOBE...

October 28 2024
UK Regulatory

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 The detailed study results confirmed interim...

October 26 2024
UK Regulatory

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference

Biogen to Present New Data at the Clinical Trials on Alzheimer's Disease (CTAD) 2024 Annual Conference CAMBRIDGE, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB...

October 24 2024
UK Regulatory

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024

Biogen Announces Late Breaker and New Data Presentations at American Society of Nephrology (ASN) Kidney Week 2024 Late breaker oral presentation to feature final results of the Phase 2 IGNAZ study...

October 22 2024
UK Regulatory

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients

Biogen Receives U.S. FDA Breakthrough Therapy Designation for Felzartamab for the Treatment of Antibody-Mediated Rejection in Kidney Transplant Recipients Designation is based on data from the...

October 09 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1-0.701508242722142.55145.2141.4516141.59538462DE
4-12.05-7.84505208333153.6155.25141.4526149.31300813DE
12-29.35-17.1737858397170.9176.15141.4541162.23778169DE
26-77.45-35.3652968037219220.7141.4538172.98576497DE
52-92.65-39.560204953234.2244.6141.4534189.0019479DE
156-74.05-34.3460111317215.6244.6141.4533189.74711799DE
260-74.05-34.3460111317215.6244.6141.4533189.74711799DE

1BIIB - Frequently Asked Questions (FAQ)

What is the current Biogen share price?
The current share price of Biogen is 141.55 €
How many Biogen shares are in issue?
Biogen has 145,719,340 shares in issue
What is the market cap of Biogen?
The market capitalisation of Biogen is EUR 20.63B
What is the 1 year trading range for Biogen share price?
Biogen has traded in the range of 141.45 € to 244.60 € during the past year
What is the PE ratio of Biogen?
The price to earnings ratio of Biogen is 18.56
What is the cash to sales ratio of Biogen?
The cash to sales ratio of Biogen is 2.19
What is the reporting currency for Biogen?
Biogen reports financial results in USD
What is the latest annual turnover for Biogen?
The latest annual turnover of Biogen is USD 9.84B
What is the latest annual profit for Biogen?
The latest annual profit of Biogen is USD 1.16B
What is the registered address of Biogen?
The registered address for Biogen is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, NEW CASTLE, WILMINGTON, DELAWARE, 19810
What is the Biogen website address?
The website address for Biogen is www.biogen.com
Which industry sector does Biogen operate in?
Biogen operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WSOGESWarr Soges Group
0.095 €
(48.44%)
2.13k
EPHEPH SpA
0.17 €
(30.77%)
7k
WSBCBSicily by Car SpA
0.0194 €
(29.33%)
9.3k
COSMOFarmacosmo spa
0.708 €
(18.00%)
92.62k
WFTC26Finanzatech Spa
0.029 €
(16.00%)
35.1k
DOTDotstay Spa
1.55 €
(-30.18%)
1.5k
WIVN26iVision Tech SpA
0.2011 €
(-16.76%)
500
WNUS26Nusco Spa
0.101 €
(-16.53%)
32.81k
1DUEDuerr AG
20.66 €
(-14.70%)
50
BSTBanca Sistema SpA
1.22 €
(-13.60%)
1.63M
TITTelecom Italia SpA
0.2426 €
(0.33%)
182.51M
ISPIntesa Sanpaolo Spa
3.8175 €
(-0.43%)
32.32M
SPMSaipem Spa
2.48 €
(-0.08%)
15.43M
TITRTelecom Italia
0.2825 €
(0.36%)
15.37M
ENELEnel Spa
6.803 €
(-0.04%)
12.73M

Discussion

View Full Feed
oldmystic oldmystic 3 minutes ago
More likely at a $25+ price after the JPM conference and publication of the peer reviewed paper.
Time will tell Bill Money
JPM
hardlesson hardlesson 3 minutes ago
$shmn Walmart Marketplace: https://x.com/sohminc/status/1871252518602485892

___
Already on Amazon too.
SHMN
learningcurve2020 learningcurve2020 4 minutes ago
LOL. IF the probability is 95% then the current share price has already made its run.  
NWBO
exwannabe exwannabe 4 minutes ago
Nice data on a few rats.

So the rat-DC did almost nothing w/o help from other agents. The arm with CSF-R1+PD-1+DC did far better. Of course no data on PD-1+CSF-R1 w/o DC to know if DC actually did much of anything ion that arm.

Even in a small rat study they can't show
NWBO
harry crumb harry crumb 4 minutes ago
Listen pal, what dont tou understand, my posts are fact not fiction, their science is, was an alwats has been a failure an a scam! The ceo is a thief! Ocgn will be .50 in the first few days of 2025! Watchvan learn dueschbag
OCGN
want2retire want2retire 4 minutes ago
"My point is that KBLB is begging for $5 million more than he has right now so that he can increase production and make deliveries.  But no one is stepping up to the plate.  Kings hasn't ever even made the $250K up-front payment they promised in the contract.  They don't seem to be willing to make a
KBLB
Rambo Rell Rambo Rell 5 minutes ago
$ILLR Upcoming Catalyst Alert
⚡ Major catalyst ahead: With a key product launch and a strategic partnership announcement on the horizon, this stock could be primed for a significant breakout. The best time to get in? Before the market reacts.
ILLR
Rambo Rell Rambo Rell 5 minutes ago
$ILLR Upcoming Catalyst Alert
⚡ Major catalyst ahead: With a key product launch and a strategic partnership announcement on the horizon, this stock could be primed for a significant breakout. The best time to get in? Before the market reacts.
ILLR
Rambo Rell Rambo Rell 5 minutes ago
$ILLR Insider Confidence is Key
📊 Follow the insiders: Recent insider buying is a huge vote of confidence in the company’s potential. These are the people who know the business best, and they’re putting their money where their mouth is. That’s a bullish signal you can’t ignore.
ILLR
maperatpogi maperatpogi 5 minutes ago
https://www.otcmarkets.com/stock/IGPK/security
IGPK
Rambo Rell Rambo Rell 5 minutes ago
$ILLR Insider Confidence is Key
📊 Follow the insiders: Recent insider buying is a huge vote of confidence in the company’s potential. These are the people who know the business best, and they’re putting their money where their mouth is. That’s a bullish signal you can’t ignore.
ILLR
MJAM2020 MJAM2020 5 minutes ago
From todays FOXO PR.

“We look forward to ending the year with our 2024 Annual General Meeting to have our shareholders approve our directors and auditors,” said Seamus Lagan, CEO of FOXO. “We will also require another Special Meeting as soon as practical for other matters needing sha
FOXO
firebag1 firebag1 5 minutes ago
Sure, whatever works. We will all just buy more merry Christmas!
I got lots of powder as they say, lol
HMBL
N4longterm N4longterm 6 minutes ago
https://youtu.be/Chv-S7XeaZ8
MIKP
Dj2490 Dj2490 6 minutes ago
Do you ever stop talking??
GDVM
glenn1919 glenn1919 6 minutes ago
gtbp....................................https://www.stockscores.com/charts/charts/?ticker=gtbp
New money98 New money98 7 minutes ago
R-Exhibits, P-exhibits, Confidentiality agreements....on another note Merry Christmas to all!!!
richme richme 7 minutes ago
Does Parity have a ticker? Can't find it in Schwab or IHUB for that matter.
MONI
justkate justkate 7 minutes ago
JUST "AND LET ME TELL YOU SOMETHING" HOLDING UNTIL THE EIGHT HUNDRED AND EIGHTY-EIGHT EIGHT-FOOT-WIDE COWS COME HOME!! POST# 99677 AND MASSIVE IMPROVEMENT SINCE FIRST SHOWN ON GOOGLE EARTH STREETVIEW ON 07-2023 AND FOR "PROPER" GOOGLE EARTH COORDINATES CHECK POST# 110792... TIS THE SEASON FOR MORE
AABB
bar1080 bar1080 7 minutes ago
Absolutely GFP, Professor Terrance Odean at Berkeley (Retired now) called the index fund the greatest invention for the average investor. I've never had any reason to doubt that. It looks like that will be true again in 2024.

My biggest investing mistake was having too much in fixed
BRK.B
PlaySmart2020 PlaySmart2020 7 minutes ago
$HMBL will bounce back strong
HMBL
Trooperstocks Trooperstocks 7 minutes ago
Worth keeping an eye on this company, especially at this price. $ILUS
ILUS
pos_stock_hoarder pos_stock_hoarder 8 minutes ago
Can January 20 come any earlier. At the rate that these treasonous American hating libtards are going, it's looking to be really bad for Trump to get things done.

Words fail me on how much I loathe these swine.
dstock07734 dstock07734 8 minutes ago
BB,

I love this part.

It's also known as cytoreductive apheresis or apheresis.) to the Advent/Sawston facility for DCVax-L manufacturing and quick return to the clinic for patient application For a breakthrough Dendritic Cell Based Platform Technology like DCVax-L in t
NWBO

Your Recent History

BIT
1BIIB
Biogen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads